Optometrists in Central Point, OR Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Dr. Graham Mcpartland, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 788 S Front St, Ste A, Central Point, OR 97502 Phone: 541-727-7501 Fax: 541-727-7775 |
 Katie Marie Goldstein, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 788 S Front St, Central Point, OR 97502 Phone: 541-727-7501 |
Dean Randolph Brown, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 650 E Pine St, Ste 105, Central Point, OR 97502 Phone: 541-664-5535 Fax: 541-664-7745 |
 Central Point Eyecare, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 650 E Pine St, Ste 105, Central Point, OR 97502 Phone: 541-664-5535 Fax: 541-664-7745 |
Dr. Angela Rachel Barnes, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3075 Hamrick Rd, Central Point, OR 97502 Phone: 541-734-2467 Fax: 541-773-2586 |
Mcpartland Medical, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 788 S Front St, Central Point, OR 97502 Phone: 541-727-7501 |
Dr. Christina Marie Mabry, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3075 Hamrick Rd, Central Point, OR 97502 Phone: 541-734-2467 Fax: 541-734-0982 |
Dr Barnes & Associates Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3075 Hamrick Rd, Central Point, OR 97502 Phone: 541-734-2467 Fax: 541-734-0982 |
News Archive
Monitoring glucose levels in brain can help predict second-wave of damage in head injury patients
Why do some of the one million people who sustain head injuries annually in United States experience a mysterious second wave of brain damage days after the initial injury - just when they appear to be recovering? Limited clinical trials using an innovative new device to monitor brain chemistry on a second-by-second basis are underway to answer that life-and-death question, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. Brain injury is the leading cause of death and disability worldwide.
Rutgers Health treats children with multiple sclerosis at the dedicated pediatric MS program
Alexander Wallerson was 12 years old when he saw a popular movie with his mother. Now 26, he remembers that specific day vividly. It was the first time he experienced the signs of multiple sclerosis (MS)."I walked like I was drunk," says Wallerson, who lives in New Brunswick. "I was limping but not in pain."
Neuren presents phase 2 clinical trial strategy for NNZ-2566
Neuren Pharmaceuticals has announced that Mr Larry Glass, Executive Vice President and head of Neuren's US operations, has been invited by the US Army to present Neuren's clinical trial strategy for NNZ-2566 at the Advanced Technology Applications for Combat Casualty Care (ATACCC) conference.
Novel method for manufacturing complex-shaped ceramic bone implants developed
Scientists from the Skoltech Center for Design, Manufacturing, and Materials (CDMM) have developed a method for designing and manufacturing complex-shaped ceramic bone implants with a controllable porous structure, which largely enhances tissue fusion efficiency.
Studies reveal complex molecular choreography with implications for human health and disease
As interactions of cellular proteins increasingly take center stage in basic biomedical research, studies are revealing a complex molecular choreography with implications for human health and disease.
› Verified 4 days ago